Steven G.F. Wassilak

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial”.

Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial

The Lancet Infectious Diseases(2023)10.1016/s1473-3099(23)00139-1

N/A

1.4DataRank · unranked

24 citations

Khalequ Zaman, Masuma Hoque, Concepción F. Estívariz, Cara C. Burns, Jennifer L. Konopka‐Anstadt +15 more

Assessing the mucosal intestinal and systemic humoral immunity of sequential schedules of inactivated poliovirus vaccine and bivalent oral poliovirus vaccine for essential immunization in Bangladesh: An open-label, randomized controlled trial

Vaccine(2024)10.1016/j.vaccine.2024.126216

N/A

0.129DataRank · unranked

1 citations

Khalequ Zaman, Concepción F. Estívariz, Asma Binte Aziz, Mohammad Yunus, Warda Haque +7 more

Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response

Vaccine(2021)10.1016/j.vaccine.2021.04.061

N/A

0DataRank · unranked

25 citations

Mark A. Pallansch, Steven G.F. Wassilak, Stephen L. Cochi, Kimberly M. Thompson, Dominika A. Kalkowska

Outbreak response strategies with type 2-containing oral poliovirus vaccines

Vaccine(2022)10.1016/j.vaccine.2022.10.060

N/A

0DataRank · unranked

20 citations

Steven G.F. Wassilak, Mark A. Pallansch, Cara C. Burns, Eric Wiesen, Elias Durry +3 more

Worst‐case scenarios: Modeling uncontrolled type 2 polio transmission

Risk Analysis(2023)10.1111/risa.14159

N/A

0DataRank · unranked

11 citations

Eric Wiesen, Steven G.F. Wassilak, Cara C. Burns, Mark A. Pallansch, Kamran Badizadegan +2 more